🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Investigators propose to test the hypothesis that GCSF therapy enhances...
Status
Completed
Location
Children's National Medical Center
Start Date
2018-01-15
Trial ID
NCT03395028
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2003-11
Trial ID
NCT00070187
This phase I trial studies the best dose of total body irradiation when giv...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2020-12-03
Trial ID
NCT04375631
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Long Beach Memorial Medical Center
Start Date
1998-11
Trial ID
NCT00003597
Treatments Being Tested
This study will compare the results of stem cell mobilization using drugs c...
Status
Completed
Location
Washington University School of Medicine
Start Date
2014-08-20
Trial ID
NCT02098109
Treatments Being Tested
A Phase 1/2a Open Label Multicenter, Non-Randomized, Trial to Assess the Sa...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-09
Trial ID
NCT05218408
Treatments Being Tested
This pilot phase I trial studies the side effects of total bone marrow and ...
Status
Suspended
Location
City of Hope Medical Center
Start Date
2018-03-19
Trial ID
NCT03467386
This randomized phase III trial studies how well gemcitabine hydrochloride ...
Status
Terminated
Location
Tennessee Valley Gynecologic Oncology
Start Date
2012-06-04
Trial ID
NCT01533207
This is an observational study of unstimulated bone marrow (BM) and filgras...
Status
Completed
Location
City of Hope
Start Date
2010-10
Trial ID
NCT01362179
This phase I/II trial studies the best dose and side effects of gemcitabine...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2012-11-21
Trial ID
NCT01629511